Crinetics Pharmaceuticals, Inc. (CRNX)

NASDAQ: CRNX · Real-Time Price · USD

35.57

-0.25 (-0.70%)

At close: Mar 20, 2026, 4:00 PM EDT

36.00

+0.43 (1.21%)

After-hours: Mar 20, 2026, 6:49 PM EDT

Crinetics Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	101.54	264.55	54.9	32.67	200.7
Short-Term Investments	926.35	1,090	503.66	301.75	133.01
Cash & Short-Term Investments	1,028	1,354	558.56	334.43	333.71
Cash Growth	-24.09%	142.42%	67.02%	0.21%	95.29%
Accounts Receivable	0.59	-	-	-	-
Inventory	2.02	-	-	-	-
Other Current Assets	17.84	21.32	15.6	10.76	11.01
Total Current Assets	1,048	1,375	574.15	345.18	344.72
Net Property, Plant & Equipment	54.79	55.58	57.43	4.99	4.72
Long-Term Investments	-	-	0.47	-	1.01
Other Long-Term Assets	23.13	3.63	3.3	2.01	0.57
Total Assets	1,126	1,435	635.35	352.18	351.02
Accounts Payable	41.77	21.47	23.2	15.35	8.47
Accrued Expenses	35.58	28.89	14.52	9.08	6.59
Current Portion of Leases	6.49	7.15	4.17	1.05	-
Unearned Revenue	1.24	2.18	2.06	2.24	-
Other Current Liabilities	-	-	-	-	0.94
Total Current Liabilities	85.07	59.68	43.94	27.72	16
Long-Term Leases	42.05	44.57	47.56	2.02	3.07
Other Long-Term Liabilities	7.05	5.53	4.75	6.1	0
Total Long-Term Liabilities	49.1	50.1	52.31	8.13	3.08
Total Liabilities	134.17	109.79	96.25	35.85	19.07
Common Stock	2,408	2,276	1,192	759.43	607.58
Treasury Stock	-0.11	-	-	-	-
Accumulated Other Comprehensive Income	1.87	0.96	0.98	-3.93	-0.38
Retained Earnings	-1,417	-952.11	-653.7	-439.17	-275.26
Shareholders' Equity	992.08	1,325	539.11	316.33	331.94
Total Liabilities & Equity	1,126	1,435	635.35	352.18	351.02
Total Debt	48.54	51.72	51.73	3.08	3.07
Net Cash (Debt)	979.35	1,302	506.83	331.35	330.63
Net Cash Growth	-24.80%	156.96%	52.96%	0.22%	98.14%
Net Cash Per Share	10.41	16.12	8.73	6.37	8.60
Book Value	992.08	1,325	539.11	316.33	331.94
Book Value Per Share	10.55	16.40	9.28	6.09	8.64
Tangible Book Value	992.08	1,325	539.11	316.33	331.94
Tangible Book Value Per Share	10.55	16.40	9.28	6.09	8.64

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q